Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

Sanjeev Sethi, Hanna Debiec, Benjamin Madden, M. Cristine Charlesworth, Johann Morelle, Lou Ann Gross, Aishwarya Ravindran, David Buob, Michel Jadoul, Fernando C. Fervenza, Pierre Ronco

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.

Original languageEnglish (US)
Pages (from-to)163-174
Number of pages12
JournalKidney international
Volume97
Issue number1
DOIs
StatePublished - Jan 2020

Fingerprint

Membranous Glomerulonephritis
Glomerular Basement Membrane
Mass Spectrometry
Antigens
EGF Family of Proteins
Immunoglobulin G
Serum
Immunohistochemistry
Microdissection
Belgium
Antigen-Antibody Complex
Epidermal Growth Factor
Confocal Microscopy
France

Keywords

  • mass spectrometry
  • membranous nephropathy
  • NELL-1

ASJC Scopus subject areas

  • Nephrology

Cite this

Sethi, S., Debiec, H., Madden, B., Charlesworth, M. C., Morelle, J., Gross, L. A., ... Ronco, P. (2020). Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney international, 97(1), 163-174. https://doi.org/10.1016/j.kint.2019.09.014

Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. / Sethi, Sanjeev; Debiec, Hanna; Madden, Benjamin; Charlesworth, M. Cristine; Morelle, Johann; Gross, Lou Ann; Ravindran, Aishwarya; Buob, David; Jadoul, Michel; Fervenza, Fernando C.; Ronco, Pierre.

In: Kidney international, Vol. 97, No. 1, 01.2020, p. 163-174.

Research output: Contribution to journalArticle

Sethi, S, Debiec, H, Madden, B, Charlesworth, MC, Morelle, J, Gross, LA, Ravindran, A, Buob, D, Jadoul, M, Fervenza, FC & Ronco, P 2020, 'Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy', Kidney international, vol. 97, no. 1, pp. 163-174. https://doi.org/10.1016/j.kint.2019.09.014
Sethi, Sanjeev ; Debiec, Hanna ; Madden, Benjamin ; Charlesworth, M. Cristine ; Morelle, Johann ; Gross, Lou Ann ; Ravindran, Aishwarya ; Buob, David ; Jadoul, Michel ; Fervenza, Fernando C. ; Ronco, Pierre. / Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. In: Kidney international. 2020 ; Vol. 97, No. 1. pp. 163-174.
@article{9508ca49ac7a458db32526165d6b43b4,
title = "Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy",
abstract = "Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70{\%} and 1-5{\%} of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.",
keywords = "mass spectrometry, membranous nephropathy, NELL-1",
author = "Sanjeev Sethi and Hanna Debiec and Benjamin Madden and Charlesworth, {M. Cristine} and Johann Morelle and Gross, {Lou Ann} and Aishwarya Ravindran and David Buob and Michel Jadoul and Fervenza, {Fernando C.} and Pierre Ronco",
year = "2020",
month = "1",
doi = "10.1016/j.kint.2019.09.014",
language = "English (US)",
volume = "97",
pages = "163--174",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

AU - Sethi, Sanjeev

AU - Debiec, Hanna

AU - Madden, Benjamin

AU - Charlesworth, M. Cristine

AU - Morelle, Johann

AU - Gross, Lou Ann

AU - Ravindran, Aishwarya

AU - Buob, David

AU - Jadoul, Michel

AU - Fervenza, Fernando C.

AU - Ronco, Pierre

PY - 2020/1

Y1 - 2020/1

N2 - Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.

AB - Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.

KW - mass spectrometry

KW - membranous nephropathy

KW - NELL-1

UR - http://www.scopus.com/inward/record.url?scp=85076263834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076263834&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2019.09.014

DO - 10.1016/j.kint.2019.09.014

M3 - Article

C2 - 31901340

AN - SCOPUS:85076263834

VL - 97

SP - 163

EP - 174

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -